Latest Research
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis. Ann Rheum Dis. July 2024
Bona fide dendritic cells are pivotal precursors for osteoclasts. Ann Rheum Dis. December 2023
A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity. Nat. Comm. October 2023
Research Group of Stephan Blüml
We analyze the mechanisms leading to joint inflammation and subsequently joint destruction, with an emphasis on the contribution of myeloid cells in that process.
Research Group of Michael Bonelli
We want to understand the mechanisms required for cell stability and identity in T cell-mediated autoimmune diseases such as Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Research Group of Silvia Hayer
Inflammatory joint damage & bone biologyWe study pathomechanisms of inflammation-mediated joint damage and systemic bone loss.
Research Group of Leonhard Heinz
Research Group of Thomas Karonitsch
Fibroblast pathology in rheumatic diseasesOur group aims to unfold the mechanisms that drive FLS activation in inflammatory joint diseases. We focus on inflammatory and metabolic pathways (e.g. mTOR pathway) that are critical for the inflammatory response in FLS.
